CN Patent

CN102940879A — 稳定化的药物肽组合物

Assigned to Novo Nordisk AS · Expires 2013-02-27 · 13y expired

What this patent protects

本发明涉及稳定化的药物肽组合物。具体地说，本发明提供了一种增加用于肠胃外给药的包含胰高血糖素样肽的药物组合物的保存期限的方法，所述药物组合物中由已在高于中性pH的pH下处理的肽产物制备而来。

USPTO Abstract

本发明涉及稳定化的药物肽组合物。具体地说，本发明提供了一种增加用于肠胃外给药的包含胰高血糖素样肽的药物组合物的保存期限的方法，所述药物组合物中由已在高于中性pH的pH下处理的肽产物制备而来。

Drugs covered by this patent

Patent Metadata

Patent number
CN102940879A
Jurisdiction
CN
Classification
—
Expires
2013-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.